FIELD: medicine, nephrology.
SUBSTANCE: the present innovation deals with introducing mildronate per 0.25 g 4 times daily about 30 min before meals for 3 wk, and then - per 0.25 g thrice daily about 30 min before meals for 4 wk at the background of daily intake of dipiridamol at the dosage of 200 mg/d. If necessary, therapeutic course should be repeated in 6 mo. The innovation improves endothelial function that leads to suppressed inflammatory process in kidneys and their improved functional capacity.
EFFECT: higher efficiency of therapy.
1 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING PATIENTS WITH CHRONIC GLOMERULONEPHRITIS COMBINED WITH CHRONIC OPISTHORCHIASIS | 2010 |
|
RU2417081C1 |
DIFFERENTIAL ESTIMATION METHOD FOR CHECKING INFLAMMATORY PROCESS ACTIVITY IN CHRONIC GLOMERULONEPHRITIS CASES | 2004 |
|
RU2261443C1 |
METHOD OF PREDICTING CHARACTER OF PROGRESSING COURSE OF CHRONIC KIDNEY DISEASE | 2010 |
|
RU2430364C1 |
METHOD FOR TREATING PATIENTS WITH CHRONIC GLOMERULONEPHRITIS | 2001 |
|
RU2194526C1 |
METHOD FOR TREATING DIABETIC POLYNEUROPATHY | 2004 |
|
RU2262928C1 |
APPLICATION OF 2-ETHYL-6-METHYL-3-OXYPYRIDINE SUCCINATE FOR TREATMENT OF NEPHRITIS AND NEPHROPATHY | 2004 |
|
RU2290930C2 |
METHOD PREDICTING CHRONIC RENAL INSUFFICIENCY AT PATIENTS WITH POSTCAPILLAROTOXIC GLOMERULONEPHRITIS | 2007 |
|
RU2333497C1 |
METHOD FOR PREDICTING THE DEVELOPMENT OF CHRONIC RENAL FAILURE AT CHRONIC GLOMERULONEPHRITIS | 2006 |
|
RU2319147C1 |
METHOD FOR DIAGNOSING SECONDARY NEPHROPATHIES IN RHEUMATIC DISEASES IN CHILDREN | 2023 |
|
RU2824052C1 |
METHOD FOR PREDICTION OF PESPONSE RATE TO IMMUNOSUPPRESSIVE THERAPY OF CHRONIC GLOMERULONEPHRITIS WITH NEPHROTIC SYNDROME | 2011 |
|
RU2453852C1 |
Authors
Dates
2005-10-20—Published
2004-04-06—Filed